Project Grant R01HD118913
- This Project Grant award of $118,320 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will assess the impact of a postpartum intrauterine device (IUD) intervention on contraceptive decision-making in Tanzania and Nepal. The key objectives are to: (1) determine if the postpartum IUD intervention led to perceived pressure to adopt contraception that influenced...
- This federal Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is funding research to study the impact of HIV and toxic metal exposures on neurodevelopmental outcomes in school-age children in East and Southern Africa. The $734,151 award will support the extension of a longitudinal study to follow a cohort of 2,000 children exposed and...
- This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865, the Child Health and Human Development Extramural Research program, aims to develop a bioadhesive vaginal film that provides extended-release delivery of contraceptive and antiviral monoclonal antibodies. The $518,754 award to Magee-Womens Research Institute And Foundation, with sub-awards to the University of Pittsburgh and Boston University Medical...
- This Project Grant award of $743,287 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) will support a multi-disciplinary research effort by Oregon Health & Science University to uncover novel insights into endocervical mucus secretion. The goal is to elucidate the cells and pathways involved in mucus changes related to hormonal shifts, with the long-term objective of using this...
- This $438,926 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a study to determine the prevalence, risk factors, and clinical progression of uterine leiomyomas (uterine fibroids) and examine differences by HIV serostatus among women in Durban, KwaZulu-Natal, South Africa. The study aims to: 1) describe the 12-month point prevalence of uterine fibroids...
- This $474,946 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) supports the development of a novel, non-hormonal, female-initiated contraceptive device. The key products or services to be delivered under this grant include: Design and fabrication of a dual-compartment vaginal device that enables women to administer a polymeric, bioresponsive "smart fiber"...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $258,556 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Johns Hopkins University. The grant, awarded on September 15, 2025, will fund a longitudinal study investigating the association of lifelong antiretroviral treatment (ART) with anti-Mullerian hormone (AMH) levels and fecundability in African women living with HIV. The study will...
- The federal Project Grant award of $791,294 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a follow-up study to an existing NIH-funded randomized controlled trial (RCT) on improving contraceptive access for women seeking care at Title X providers. The study aims to: (1) link RCT participants to administrative records 3-5 years after enrollment,...
- This $233,250 Project Grant was awarded on September 25, 2025 by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865). The grant funds a project to evaluate the extent and outcomes of isoniazid exposure during pregnancy among infants born to women living with HIV in Kenya. The project aims to quantify isoniazid exposure in pregnant women receiving tuberculosis...
- The National Institute of Child Health and Human Development (NICHD) awarded a $2,052,694 Cooperative Agreement under CFDA 93.865, the Child Health and Human Development Extramural Research program, to the University of Washington. The award, titled "Researching Interventions and Implementation Strategies to Evaluate the Health and Development of Children Affected by HIV in Southern and Eastern Africa (RISE)", will support a multi-country study with 34 research projects and 3 cores....
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under CFDA 93.865 - Child Health and Human Development Extramural Research program, provides $751,405.00 to Seattle Children's Hospital (doing business as Seattle Children's Research Institute) to conduct a randomized trial investigating the effects of copper versus levonorgestrel intrauterine devices (IUDs) on mucosal microbiota and barrier function in young African women living with and at risk for HIV. The key objectives are to assess how the use of copper IUDs versus hormonal IUDs impacts the vaginal microbiome, genital inflammation, and mucosal barrier integrity in this population. This research aims to provide important insights into potential reproductive health implications and adverse outcomes associated with the different IUD types, which is critical given the importance of access to safe contraceptive options for women living with or at risk of HIV. The award period runs from September 22, 2025 through May 31, 2030.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $751.4k | 9/22/25 |